(HealthDay)—For patients with evolved melanoma, response to immune checkpoint inhibitors (ICIs) is linked for those with and without preexisting autoimmune illness (AID), constant with a…
(HealthDay)—For patients with evolved melanoma, response to immune checkpoint inhibitors (ICIs) is linked for those with and without preexisting autoimmune illness (AID), constant with a…